IJMS | Free Full-Text | The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance | HTML
Frontiers | Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma | Pharmacology
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Figure 1 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram
Sorafenib: 10 years after the first pivotal trial | Future Oncology
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Mechanism of Action | NEXAVAR® (sorafenib) Global HCP Website
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library
Sorafenib - Mechanism of Action in treating Advanced Hepatocellular Carcinoma
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
IJMS | Free Full-Text | Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment | HTML
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
Sorafenib (NEXAVAR)®
Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library
Pexa-Vec/Nexavar Combination Fails Phase III Trial in Liver Cancer
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
Combining Celecoxib with Sorafenib Synergistically Inhibits Hepatocellular Carcinoma Cells In Vitro | Anticancer Research
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. - Abstract - Europe PMC
